TNO155 |
| Katalog-Nr.GC39514 |
TNO155 ist ein potenter selektiver und oral aktiver allosterischer Inhibitor von Wildtyp-SHP2 (IC50=0,011 μ M). TNO155 hat das Potenzial fÜr die Untersuchung von RTK-abhÄngigen malignen Erkrankungen, insbesondere von fortgeschrittenen soliden Tumoren.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1801765-04-7
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
TNO155 is a potent selective and orally active allosteric inhibitor of wild-type SHP2 (IC50=0.011 µM). TNO155 has the potential for the study of RTK-dependent malignancies, especially advanced solid tumors[1].
[1]. TNO155: SHP2 inhibitor
Average Rating: 5 (Based on Reviews and 24 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *